One's grandparents as the determinant of effective antihypertensive therapy Norman K. Hollenberg Brigham and Women's Hospital and Harvard Medical School, Departments of Radiology and Medicine, Boston, Massachusetts, USA

Blood Pressure Monitoring

Volumn 4, Issue SUPPL. 1, 1999, Pages

  Hollenberg, N K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Ambulatory blood pressure; Angiotensin converting enzyme inhibition; Genetics; Lisinopril

Indexed keywords

AMILORIDE; ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL;

BLOOD PRESSURE; CLINICAL TRIAL; CONFERENCE PAPER; DEMOGRAPHY; DNA POLYMORPHISM; DRUG RESPONSE; FAMILIAL DISEASE; HUMAN; HYPERTENSION; META ANALYSIS; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL;

NON-PROGRAMMATIC;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION;

EID: 0033510426     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In Laragh JH, Brenner BM (editors): Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven Press; 1990. pp. 81-100.
2. Allemann Y, Weidmann P. Cardiovascular, metabolic and hormonal dysregulation in normotensive offspring of essential hypertensive patients. J Hypertens 1995; 13:162-172.
3. Williams R, Hunt SC, Hopkins PN, Hasstedt SJ, Wu LL, Lalouel JM. Tabulations and expectations regarding the genetics of human hypertension. Kid Int Suppl 1994; 45:57-64.
4. Luft FC, Schuster H, Bilginturan N, Wienker T. Treasure your exceptions: what we can learn from autosomal-dominant inherited forms of hypertension. J Hypertens 1995; 13:1535-1538.
5. Soubrier F, Lathrop GM. The genetic basis of hypertension. Curr Opin Nephrol Hypertens 1995; 4:177-181.
6. Sing CF, Boerwinkle E, Turner ST. Genetics of primary hypertension. Clin Exp Theory Pract 1986; A8:623-651.
7. Lifton RP, DIuhy RG, Powers M, Rich GM, Cook S, Ulick S, et al. A chimeric 11 p-hydroxylase/aldosterone synthase gene causes glucocorticoidremediable aldosteronism and human hypertension. Nature 1992; 355:262265.
8. Pascoe L, Jeunemaitre X, Lebrethon M-C, Curnow KM, Gomez-Sanchez CE, Gase J-M, et al. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J Clin Invest 1995; 96:22362246.
9. Shimkets RA, Wamock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, et al. Little's syndrome: heritable human hypertension caused by mutations in the subunit of the epithelial sodium channel. Cell 1994; 79:407-414.
10. Hingorani AD, Jia H, Stevens PA, Hopper R, Dickerson JEC, Brown MJ. Renin-angiotensin system gene polymorphisms influence BP and the response to ACE inhibition. J Hypertens 1995; 13:1602-1609.
11. Todd GP, Chadwick IG, Higgins KS, Yeo WW, Jackson PR, Ramsay LE. Relation between changes in B P and serum ACE activity after a single dose of enalapril and ACE genotype in healthy subjects. Br J Clin Pharmacol 1995; 39:131-134.
12. Dudley C, Keavney B, Casadei B, Conway J, Bird R, Ratcliffe P. Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of RAS genes. J Hypertens 1996; 14:259-262.
13. Bennett C, Schrader AP, Morris BJ. Cross-sectional analysis of METJ35STHR variant of AGT gene in severe, familial hypertension. Biochem Biophys Res Commun 1993; 197:833-839.
14. Jeunemaitre X, Soubrier F, Koeletsev YV, Lifton RP, Williams CS, Charu A, et al. Molecular basis of human hypertension: role of AGT. Cell 1992; 71:169180.
15. Bloem U, Manatunga AK, Tewksbury DA, Pratt JH. The serum AGT concentration and variants of the AGT gene in white and black children. J Clin Invest 1995; 95:948-953.
16. Caufield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, er al. Linkage of the AGT gene to essential hypertension. A/ Engl J Med 1994; 330:1629-1633.
17. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K. AGT as a risk factor for essential hypertension in Japan. J Clin Invest 1994; 93:12851287.
18. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Tomoda S, et al. A molecular variant of AGT associated with preeclampsia. Nat Genet 1993; 4:59-61.
19. Regele RA, Brunt JH, Connelly PW. A polymorphism of AGT gene associated with variation in BP in a genetic isolate. Circulation 1994; 90:2207-2212.
20. Rotimi C, Morrison L, Cooper R, Oyejide C, Effiong E, Ladipo M, et al. AGT gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension 1994; 24:591-594.
21. Caufield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, et al. Linkage of the AGT gene locus to human essential hypertension in African Caribbean's. J Clin Invest 1995; 96:687-692.
22. Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaitre X, Hallouin M-C, Skuppin J, et al. Blunted renovascular response to Angll is associated with a common variant of the AGT gene and obesity. J Hypertens 1996; 14:199207.
23. Hollenberg NK, Williams GH. Abnormal renal function, sodium-volume homeostasis and renin system hypertension: the evolution of the nonmodulator concept. In Laragh JH, Brenner, BM (editors): Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn. Raven Press: New York; 1995; 2: pp. 1837-1856.